Insider Transactions in Q1 2021 at Nu Skin Enterprises, Inc. (NUS)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2021
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-3.76%
|
$520,000
$52.65 P/Share
|
|
Mar 15
2021
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+9.82%
|
$300,000
$30.63 P/Share
|
|
Mar 10
2021
|
Edwina D Woodbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.1%
|
$561
$51.24 P/Share
|
|
Mar 09
2021
|
Joseph Y Chang Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
626
-3.37%
|
$31,926
$51.55 P/Share
|
|
Mar 04
2021
|
Ryan S Napierski President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,154
-1.39%
|
$56,546
$49.68 P/Share
|
|
Mar 04
2021
|
Joseph Y Chang Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
499
-2.62%
|
$24,451
$49.68 P/Share
|
|
Mar 04
2021
|
D Matthew Dorny General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
331
-0.67%
|
$16,219
$49.68 P/Share
|
|
Mar 04
2021
|
Ritch N Wood Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,795
-1.3%
|
$136,955
$49.68 P/Share
|
|
Mar 02
2021
|
Mark H Lawrence Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
910
-1.74%
|
$46,410
$51.66 P/Share
|
|
Mar 01
2021
|
D Matthew Dorny General Counsel |
SELL
Open market or private sale
|
Direct |
12,400
-10.58%
|
$644,800
$52.12 P/Share
|
|
Mar 01
2021
|
D Matthew Dorny General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
12,400
+16.69%
|
$372,000
$30.63 P/Share
|
|
Feb 18
2021
|
Daniel W Campbell Director |
BUY
Open market or private purchase
|
Indirect |
5,055
+33.55%
|
$247,695
$49.48 P/Share
|
|
Feb 18
2021
|
Daniel W Campbell Director |
BUY
Open market or private purchase
|
Direct |
5,055
+5.56%
|
$247,695
$49.49 P/Share
|
|
Feb 18
2021
|
Joseph Y Chang Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,125
-5.57%
|
$55,125
$49.77 P/Share
|
|
Feb 17
2021
|
Steven Lund Exec. Chairman of the Board |
BUY
Open market or private purchase
|
Indirect |
20,850
+7.97%
|
$1,000,800
$48.05 P/Share
|
|
Feb 17
2021
|
Daniel W Campbell Director |
BUY
Open market or private purchase
|
Indirect |
4,955
+50.0%
|
$247,750
$50.69 P/Share
|
|
Feb 17
2021
|
Daniel W Campbell Director |
BUY
Open market or private purchase
|
Direct |
4,955
+5.78%
|
$247,750
$50.6 P/Share
|
|
Feb 16
2021
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
7,000
-2.64%
|
$343,000
$49.56 P/Share
|
|
Feb 16
2021
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+7.22%
|
$210,000
$30.63 P/Share
|
|
Feb 15
2021
|
Joseph Y Chang Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,179
-5.52%
|
$56,592
$48.81 P/Share
|
|
Feb 15
2021
|
Joseph Y Chang Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,557
+23.48%
|
-
|
|
Feb 15
2021
|
Mark H Lawrence Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,339
-9.28%
|
$256,272
$48.81 P/Share
|
|
Feb 15
2021
|
Mark H Lawrence Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,015
+13.55%
|
-
|
|
Feb 15
2021
|
James D Thomas Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
710
-7.42%
|
$34,080
$48.81 P/Share
|
|
Feb 15
2021
|
James D Thomas Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,459
+20.44%
|
-
|
|
Feb 15
2021
|
D Matthew Dorny General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,161
-2.29%
|
$55,728
$48.81 P/Share
|
|
Feb 15
2021
|
D Matthew Dorny General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,278
+11.03%
|
-
|
|
Feb 15
2021
|
Ritch N Wood Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,546
-3.83%
|
$410,208
$48.81 P/Share
|
|
Feb 15
2021
|
Ritch N Wood Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,910
+9.68%
|
-
|
|
Feb 15
2021
|
Ryan S Napierski President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,720
-4.29%
|
$178,560
$48.81 P/Share
|
|
Feb 15
2021
|
Ryan S Napierski President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,235
+13.24%
|
-
|
|
Jan 20
2021
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
10,156
-12.14%
|
$599,204
$59.12 P/Share
|
|
Jan 20
2021
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,400
+9.12%
|
$252,000
$30.63 P/Share
|
|
Jan 15
2021
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
7,000
-8.51%
|
$385,000
$55.45 P/Share
|
|
Jan 15
2021
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+7.84%
|
$210,000
$30.63 P/Share
|
|
Jan 07
2021
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
4,844
-6.05%
|
$285,796
$59.05 P/Share
|
|
Jan 07
2021
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,600
+1.96%
|
$48,000
$30.63 P/Share
|
|
Jan 04
2021
|
D Matthew Dorny General Counsel |
SELL
Open market or private sale
|
Direct |
6,200
-6.23%
|
$341,000
$55.22 P/Share
|
|
Jan 04
2021
|
D Matthew Dorny General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,200
+10.92%
|
$186,000
$30.63 P/Share
|